Citizens JMP downgraded ProAssurance from Mkt Outperform to Mkt Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | Mkt Perform → Underperform | Raymond James | |
| 4/3/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 11/11/2024 | $18.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2023 | $21.00 | Neutral | Janney |
| 8/10/2021 | $23.00 → $26.00 | Neutral → Overweight | Piper Sandler |
8-K - PROASSURANCE CORP (0001127703) (Filer)
8-K - PROASSURANCE CORP (0001127703) (Filer)
DEFM14A - PROASSURANCE CORP (0001127703) (Filer)
ProAssurance Corporation (NYSE:PRA) today announced that stockholders have voted overwhelmingly to approve its proposed acquisition by The Doctors Company. More than 99% of shares voted (including abstentions) were in favor of the proposal to approve the acquisition agreement. The transaction remains subject to the receipt of regulatory approvals and other customary closing conditions and is expected to close in the first half of 2026. Required regulatory approvals include the expiration or early termination of the waiting period (and any extension thereof) applicable to the consummation of the merger under the Hart-Scott-Rodino Act as well as approvals by the insurance regulators in the
PHILADELPHIA, June 10, 2025 /PRNewswire/ -- The Board of Trustees of abrdn Income Credit Strategies Fund (the "Fund"), has declared a cash distribution of $0.328125 per share of the Fund's 5.250% Series A Perpetual Preferred Shares (NYSE: ACP PRA) ("Series A Preferred Shares"). The distribution is payable on June 30, 2025, to holders of Series A Preferred Shares of record on June 20, 2025 (ex-dividend date June 20, 2025). The Series A Preferred Shares trade on the NYSE under the symbol "ACP PRA", are rated "A2" by Moody's Investors Service and have an annual dividend rate of $
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported a net loss of $5.8 million, or $0.11 per diluted share, and operating income(1) of $6.8 million, or $0.13 per diluted share, for the three months ended March 31, 2025. Highlights(2) First-quarter performance demonstrated continued progress in our efforts to achieve premium rate levels appropriate for the challenging conditions in the medical professional liability and workers' compensation markets; net results were impacted by non-operating items totaling $12.6 million. Details on those non-operating items can be found under the heading "Re